Suscribirse

Allergy-related outcomes in relation to serum IgE: Results from the National Health and Nutrition Examination Survey 2005-2006 - 11/08/11

Doi : 10.1016/j.jaci.2010.12.1106 
Päivi M. Salo, PhD a, Agustin Calatroni, MA, MS b, Peter J. Gergen, MD, MPH c, Jane A. Hoppin, ScD a, Michelle L. Sever, MSPH a, Renee Jaramillo, MStat d, Samuel J. Arbes, DDS, MPH, PhD b, Darryl C. Zeldin, MD a,
a National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 
b Rho, Inc, Chapel Hill, NC 
c National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md 
d SRA International, Inc, Durham, NC 

Reprint requests: Darryl C. Zeldin, MD, NIEHS/NIH, 111 T.W. Alexander Dr, Room A222, Research Triangle Park, NC 27709.

Abstract

Background

The National Health and Nutrition Examination Survey (NHANES) 2005-2006 was the first population-based study to investigate levels of serum total and allergen-specific IgE in the general US population.

Objective

We estimated the prevalence of allergy-related outcomes and examined relationships between serum IgE levels and these outcomes in a representative sample of the US population.

Methods

Data for this cross-sectional analysis were obtained from NHANES 2005-2006. Study subjects aged 6 years and older (n = 8086) had blood taken for measurement of total IgE and 19 specific IgE levels against common aeroallergens, including Alternaria alternata, Aspergillus fumigatus, Bermuda grass, birch, oak, ragweed, Russian thistle, rye grass, cat dander, cockroach, dog dander, dust mite (Dermatophagoides farinae and Dermatophagoides pteronyssinus), mouse and rat urine proteins, and selected foods (egg white, cow’s milk, peanut, and shrimp). Serum samples were analyzed for total and allergen-specific IgE by using the Pharmacia CAP System. Information on allergy-related outcomes and demographics was collected by questionnaire.

Results

In NHANES 2005-2006, 6.6% reported current hay fever, and 23.5% had current allergies. Allergy-related outcomes increased with increasing total IgE levels (adjusted odds ratios for a 10-fold increase in total IgE level of 1.86 [95% CI, 1.44-2.41] for hay fever and 1.64 [95% CI, 1.41-1.91] for allergies). Increased levels of plant-, pet-, and mold-specific IgE contributed independently to allergy-related symptoms. The greatest increase in odds was observed for hay fever and plant-specific IgE (adjusted odds ratio, 4.75; 95% CI, 3.83-5.88).

Conclusion

In the US population self-reported allergy symptoms are most consistently associated with increased levels of plant-, pet-, and mold-specific IgE.

El texto completo de este artículo está disponible en PDF.

Key words : Allergen, allergy, allergic sensitization, serum IgE

Abbreviations used : NHANES, OR


Esquema


 Supported by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences.
 Disclosure of potential conflict of interest: S. J. Arbes is employed by Rho, Inc, and has a contract with the National Institute of Dental and Craniofacial Research/National Institutes of Health. The rest of the authors have declared that they have no conflict of interest.


© 2011  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 127 - N° 5

P. 1226 - mai 2011 Regresar al número
Artículo precedente Artículo precedente
  • Fruit and vegetable consumption in relation to allergy: Disease-related modification of consumption?
  • Helen Rosenlund, Inger Kull, Göran Pershagen, Alicja Wolk, Magnus Wickman, Anna Bergström
| Artículo siguiente Artículo siguiente
  • Adhesion of Streptococcus pneumoniae to human airway epithelial cells exposed to urban particulate matter
  • Naseem Mushtaq, Majid Ezzati, Lucinda Hall, Iain Dickson, Michael Kirwan, Ken M.Y. Png, Ian S. Mudway, Jonathan Grigg

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.